ClinicalTrials.Veeva

Menu

Non-invasive Preoperative Tissue Evaluation in Head and Neck Tumor Patients Using Multispectral Optoacoustic Tomography (MSOT) (msotcmfflap)

U

University of Erlangen-Nürnberg Medical School

Status

Enrolling

Conditions

Healthy
Head and Neck Cancer

Treatments

Device: Multispectral Optoacoustic Tomography (MSOT)

Study type

Observational

Funder types

Other

Identifiers

NCT06716892
24-335-B

Details and patient eligibility

About

Multispectral Optoacoustic Tomography (MSOT) is a promising imaging technology that utilizes pulsed laser light. One of the key capabilities of this technology is measuring oxygenation within human tissue. This proposed study aims to investigate possible limitations of human tissue used for reconstructive surgery due to flawed tissue perfusion.

Healthy volunteers as well as patients with a diagnosed head and neck cancer entity will be recruited. Both cohorts will then be scanned on different body areas (most common tissue sites used for reconstructive surgery on the back, arms and legs) to assess differences in muscle oxygenation between the healthy and tumor patient cohort using MSOT.

The hypothesis of the study is, that patients with diagnosed head and neck cancer entities are prone to compromised tissue perfusion due to a high prevalence of smoking within the head neck tumor patient cohort and therefore perfusion restirciting diseases e.g. peripheral arterial occlusive disease (PAOD).

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Cohort 1: Histopathological diagnosed head and neck tumor patients.
  • Cohort 2: Healthy adults.

Exclusion criteria

  • Pregnancy / breastfeeding
  • ink / tattoo in the areas of interest (upper back, distal forearm, upper and lower leg)
  • missing consent form
  • Cohort 2: Chronical abuse of alcohol and nicotine.

Trial design

40 participants in 2 patient groups

Healthy
Description:
Healthy adult volunteers. Exclusion criteria: Chronical abuse of alcohol and nicotine, pregnancy and breastfeeding, ink / tattoo in the areas of interest (upper back, distal forearm, upper and lower leg)
Treatment:
Device: Multispectral Optoacoustic Tomography (MSOT)
Head and neck cancer patients.
Description:
Patients with histopathological diagnosed head and neck cancer.
Treatment:
Device: Multispectral Optoacoustic Tomography (MSOT)

Trial contacts and locations

1

Loading...

Central trial contact

Felix Wachter; Jonas Wolf, Dr. med.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems